Peter De Muth is Chief Scientific Officer of Angion Biomedica Corp.. Currently has a direct ownership of 381 shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on Dec 16, 2024, when has been sold 381 shares (Common Stock) at a price of $4.41 per share, resulting in proceeds of $1,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 381
n/a 3M change
n/a 12M change
Total Value Held $0

Peter DeMuth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2024
BUY
Exercise of conversion of derivative security
$1,680 $4.41 p/Share
381 Added 50.0%
381 Common Stock
PD

Peter De Muth

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on ANGN

Follow Angion Biomedica Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGN shares.

Notify only if

Insider Trading

Get notified when an Angion Biomedica Corp. insider buys or sells ANGN shares.

Notify only if

News

Receive news related to Angion Biomedica Corp.

Track Activities on ANGN